GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Total Assets

Wai Yuen Tong Medicine Holdings (HKSE:00897) Total Assets : HK$6,584 Mil (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Total Assets?

Wai Yuen Tong Medicine Holdings's Total Assets for the quarter that ended in Sep. 2023 was HK$6,584 Mil.

Warning Sign:

If a company builds assets at 21% a year, faster than its revenue growth rate of 14.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Wai Yuen Tong Medicine Holdings's average Total Assets Growth Rate was -3.20% per year. During the past 3 years, the average Total Assets Growth Rate was -3.40% per year. During the past 5 years, the average Total Assets Growth Rate was 21.00% per year. During the past 10 years, the average Total Assets Growth Rate was 16.70% per year.

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest 3-Year average Total Assets Growth Rate was 39.70%. The lowest was -3.40%. And the median was 13.20%.

Total Assets is connected with ROA %. Wai Yuen Tong Medicine Holdings's annualized ROA % for the quarter that ended in Sep. 2023 was 0.10%. Total Assets is also linked to Revenue through Asset Turnover. Wai Yuen Tong Medicine Holdings's Asset Turnover for the quarter that ended in Sep. 2023 was 0.10.


Wai Yuen Tong Medicine Holdings Total Assets Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Total Assets Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,454.67 7,730.18 7,964.53 7,597.71 7,013.82

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,032.78 7,597.71 6,914.20 7,013.82 6,583.96

Wai Yuen Tong Medicine Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Wai Yuen Tong Medicine Holdings's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets=Total Equity (A: Mar. 2023 )+Total Liabilities (A: Mar. 2023 )
=3688.384+3325.431
=7,014

Wai Yuen Tong Medicine Holdings's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets=Total Equity (Q: Sep. 2023 )+Total Liabilities (Q: Sep. 2023 )
=3485.736+3098.226
=6,584

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Total Assets Explanation

Total Assets is connected with ROA %.

Wai Yuen Tong Medicine Holdings's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=7.098/( (7013.815+6583.962)/ 2 )
=7.098/6798.8885
=0.10 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Wai Yuen Tong Medicine Holdings's Asset Turnover for the quarter that ended in Sep. 2023 is

Asset Turnover
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Mar. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=678.804/( (7013.815+6583.962)/ 2 )
=678.804/6798.8885
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Wai Yuen Tong Medicine Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines